证券记录 · 已归档季度
ABT
Abbott Laboratories · Healthcare · Medical - Devices
19被追踪持有人
n/aΔ持有人
110.87M持有股份
$11.51B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 8.65M | $848.35M | n/a | n/a |
| Q2 2026 | 180 | 0 | 1.09B | $98.86B | +5 | −6 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | n/a |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | n/a | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | n/a | 110.87M | $11.51B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 34.41M | n/a | $3.57B | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 25.53M | n/a | $2.65B | 0.5% | n/c | 1 | SEC ↗ ×8 |
| 3 | Norges Bank ✦ (被动) | 20.36M | n/a | $2.12B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Fisher Asset Management ✦ | 10.52M | n/a | $1.09B | 0.5% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 4.06M | n/a | $422.13M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | Two Sigma Investments ✦ | 2.38M | n/a | $247.25M | 0.6% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 2.33M | n/a | $241.93M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 2.30M | n/a | $239.03M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 1.67M | n/a | $173.37M | 0.9% | n/c | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 1.65M | n/a | $171.94M | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.56M | n/a | $162.35M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.02M | n/a | $105.87M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 983.92K | n/a | $102.24M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 14 | PRIMECAP Management ✦ | 930.93K | n/a | $96.73M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 871.20K | n/a | $90.42M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 16 | Marshall Wace ✦ | 216.34K | n/a | $22.48M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 34.73K | n/a | $3.61M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 22.96K | n/a | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 17.86K | n/a | $1.86M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3,058 持有人, 1.35B 股份, $133.47B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
MCCOY JOHN A. JR.
Officer · 27 股 · $2,958
Aug 25
Ford Robert B
Officer, Director · 180.30K 股 · $20.95M
Aug 25
Ford Robert B
Officer, Director · 218.53K 股 · $25.26M
Aug 11
Morrone Louis H.
Officer · 5.85K 股 · $642,506
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据